Corinna Lang-Schwarz

Corinna Lang-Schwarz

Auto-generated profile, based on publicly available information

Corinna Lang-Schwarz

Institute of Pathology, Klinikum Bayreuth Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Bayreuth Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2021 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
MAMiriam Angeloni
Miriam Angeloni
AAAbbas Agaimy
Abbas Agaimy
RARaja Atreya
Raja Atreya
CBChristoph Becker
Christoph Becker
MVMichael Vieth
Michael Vieth
Background and Aims: Histological scoring plays a key role in the assessment of disease activity in ulcerative colitis [UC] and is also important in Crohn´s disease [CD]. Currently, there is no common scoring available for UC and CD. We aimed to validate the Inflammatory Bowel Disease [IBD]—Distribution [D], Chronicity [C], Activity [A] score [IBD-DCA score] for histological disease activity assessment in IBD. Methods: Inter- and intra-rater reliability were assessed by 16 observers on biopsy specimens from 59 patients with UC and 25 patients with CD. Construct validity and responsiveness to treatment were retrospectively evaluated in a second cohort of 30 patients. Results: Inter-rater reliability was moderate to good for the UC cohort (intraclass correlation coefficients [ICCs] = 0.645, 0.623, 0.767 for D, C, and A, respectively) and at best moderate for the CD cohort [ICC = 0.690, 0.303, 0.733 for D, C, and A, respectively]. Intra-rater agreement ranged from good to excellent in both cohorts. Correlation with the Nancy Histological Index [NHI] was moderate and strong with the Simplified Geboes Score [SGS] and a Visual Analogue Scale [VAS], respectively. Large effect sizes were obtained for all three parameters. External responsiveness analysis revealed correlated changes between IBD-DCA score and NHI, SGS and VAS. Conclusions: The IBD-DCA score is a simple histological activity score for UC and CD, agreed and validated by a large group of IBD specialists. It provides reliable information on treatment response. Therefore, it has potential value for use in routine diagnostics as well as clinical studies.

1 September 2018 in Human Pathology
Verified
Journal Article
Closed access
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
BMBalint Melcher
Balint Melcher
FHFranziska Haumaier
Franziska Haumaier
KLKlaus Lang-Schwarz
Klaus Lang-Schwarz
TRThomas Rupprecht
Thomas Rupprecht
WSWilliam Sterlacci
William Sterlacci

9 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DFDaniel Firmbach
Daniel Firmbach
MBMichaela Benz
Michaela Benz
PKPetr Kuritcyn
Petr Kuritcyn
VBVolker Bruns
Volker Bruns
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
Carol GeppertCarol Geppert
Carol Geppert
The tumor–stroma ratio (TSR) has been repeatedly shown to be a prognostic factor for survival prediction of different cancer types. However, an objective and reliable determination of the tumor–stroma ratio remains challenging. We present an easily adaptable deep learning model for accurately segmenting tumor regions in hematoxylin and eosin (H&E)-stained whole slide images (WSIs) of colon cancer patients into five distinct classes (tumor, stroma, necrosis, mucus, and background). The tumor–stroma ratio can be determined in the presence of necrotic or mucinous areas. We employ a few-shot model, eventually aiming for the easy adaptability of our approach to related segmentation tasks or other primaries, and compare the results to a well-established state-of-the art approach (U-Net). Both models achieve similar results with an overall accuracy of 86.5% and 86.7%, respectively, indicating that the adaptability does not lead to a significant decrease in accuracy. Moreover, we comprehensively compare with TSR estimates of human observers and examine in detail discrepancies and inter-rater reliability. Adding a second survey for segmentation quality on top of a first survey for TSR estimation, we found that TSR estimations of human observers are not as reliable a ground truth as previously thought.

1 July 2019 in Human Pathology
Verified
Journal Article
Closed access
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
BMBalint Melcher
Balint Melcher
FHFranziska Haumaier
Franziska Haumaier
ASAnna Schneider-Fuchs
Anna Schneider-Fuchs
KLKlaus Lang-Schwarz
Klaus Lang-Schwarz
WSWilliam Sterlacci
William Sterlacci

20 November 2023 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
MBMaike Büttner-Herold
Maike Büttner-Herold
SBStephan Burian
Stephan Burian
RERamona Erber
Ramona Erber
AHArndt Hartmann
Arndt Hartmann
SBSimone Bertz
Simone Bertz
Aims Special histomorphological subtypes of colorectal low-grade intraepithelial neoplasia (LGIN) with variable prognostic impact were recently described in patients with inflammatory bowel disease (IBD) referred to as non-conventional dysplasia. However, they can also be found in patients without IBD. We aimed to analyse the reproducibility, frequency and prognostic impact of non-conventional colorectal LGIN in patients with and without IBD. Methods Six pathologists evaluated 500 specimens of five different LGIN-cohorts from patients with and without IBD. Non-conventional LGIN included hypermucinous, goblet cell-deficient, Paneth cell-rich and crypt cell dysplasia. A goblet cell-rich type and non-conventional LGIN, not otherwise specified were added. Results were compared with the original expert-consented diagnosis from archived pathology records. Results Four or more pathologists agreed in 86.0% of all cases. Non-conventional LGIN was seen in 44.4%, more frequently in patients with IBD (52%; non-IBD: 39.3%, p=0.005). In patients with IBD non-conventional LGIN associated with more frequent and earlier LGIN relapse (p=0.006, p=0.025), high-grade intraepithelial neoplasia (p=0.003), larger lesion size (p=0.001), non-polypoid lesions (p=0.019) and additional risk factors (p=0.034). Results were highly comparable with expert-consented diagnoses. In patients without IBD, non-conventional LGIN may indicate a higher risk for concurrent or subsequent colorectal carcinoma (CRC, p=0.056 and p=0.061, respectively). Frequencies and association with high-grade intraepithelial neoplasia or CRC varied between the different LGIN subtypes. Conclusions Non-conventional histomorphology in colorectal LGIN is frequent and highly reproducible. Our results indicate an increased risk for CRC in patients with non-conventional LGIN, probably independent of IBD. We recommend reporting non-conventional LGIN in routine pathology reports.

25 June 2021 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
CLCorinna Lang-Schwarz
Corinna Lang-Schwarz
BMBalint Melcher
Balint Melcher
AHArndt Hartmann
Arndt Hartmann
SBSimone Bertz
Simone Bertz
TDTheresa Dregelies
Theresa Dregelies
WSWilliam Sterlacci
William Sterlacci
Purpose: To analyze the role of programmed death ligand 1 (PD-L1) immunohistochemisty in the context of tumor microenvironment in colon cancer (CC) with focus on the interaction between tumor budding and tumor-infiltrating lymphocytes (TILs) and to elucidate its potential value for immunooncologic treatment decisions. Methods: Three hundred forty seven patients with CC, stages I to IV, were enrolled. PD-L1 immunohistochemistry was performed using two different antibodies (clone 22C3 pharmDx, Agilent and clone QR1, Quartett). Tumor proportion score (TPS) as well as immune cell score (IC) was assessed. Budding and TILs were assessed according to the criteria of the International Tumor Budding Consensus Conference (ITBCC) and International TILs Working Group (ITWG). Correlation analyses as well as survival analyses were performed. Results: PD-L1 positivity significantly correlated with TILs > 5% and MMR deficiency, and PD-L1-positive cases (overall and IC) showed significantly longer overall survival (OS) with both antibodies.The parameters “high grade,” “right-sidedness,” and “TILS > 5% regardless of MMR status” evolved as potential parameters for additional immunological treatment decisions. Additionally, TPS positivity correlated with low budding. More PD-L1-positive cases were seen in both high TIL groups. The low budding/high TIL group showed longer disease-free survival and longer OS in PD-L1-positive cases. Conclusion: Overall, PD-L1 positivity correlated with markers of good prognosis. PD-L1 immunohistochemistry was able to identify parameters as additional potential candidates for immune therapy. Furthermore, it was able to stratify patients within the low budding/high TIL group with significant prognostic impact.